0001437749-19-021587.txt : 20191105
0001437749-19-021587.hdr.sgml : 20191105
20191105160208
ACCESSION NUMBER: 0001437749-19-021587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191101
FILED AS OF DATE: 20191105
DATE AS OF CHANGE: 20191105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANDBERG RICHARD A
CENTRAL INDEX KEY: 0001245055
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 191193215
MAIL ADDRESS:
STREET 1: 330 NEVEDA STREET
CITY: NEWTON
STATE: MA
ZIP: 02460-1458
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-11-01
0001586049
Oxford Immunotec Global PLC
OXFD
0001245055
SANDBERG RICHARD A
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
Ordinary Shares
2019-11-01
4
M
0
1650
0.09
A
1650
D
Ordinary Shares
2019-11-01
4
M
0
1350
8.65
A
3000
D
Ordinary Shares
2019-11-01
4
S
0
3000
15.60
D
0
D
Stock Option (Right to Buy)
0.09
2019-11-01
4
M
0
1650
0
D
2020-03-31
Ordinary Shares
1650
0
D
Stock Option (Right to Buy)
8.65
2019-11-01
4
M
0
1350
0
D
2026-06-28
Ordinary Shares
1350
6107
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017.
Exercise from an option granted February 18, 2010, which became fully vested on April 1, 2014.
Exercise from an option granted June 28, 2016, which became fully vested on June 6, 2017.
/s/ Matthew T E McLaughlin, as Attorney-in-Fact for Richard A. Sandberg
2019-11-05